Rua-Figueroa, I.Rua-Figueroa, D.Anzola Alfaro, A. M.Perez-Veiga, N.Galindo-Izquierdo, M.Calvo-Alen, J.Fernandez-Nebro, A.Menor-Almagro, R.Sanguesa, C.Tomero Muriel, E.Del-Val, N.Uriarte Isacelaya, E.Blanco, R.Boteanu, A.Narvaez, J.Andreu Sanchez, J. L.Cobo-Ibanez, T.Montilla-Morales, C. A.Freire Gonzalez, M.Bohorquez, C.Saenz de Miera, F. J. ToyosSalas, E.Bernal, J. A.Salgado Perez, E.Exposito, L.Mas, A. J.Hernandez Beriain, J. A.Velloso Feijoo, M.Lozano Rivas, N.Bonilla, G.Quevedo Vila, V.Moreno, M.Jimenez-Moleon, I.Ibarguengoitia, O.Pecondon, A.Aurrecoechea, E.Valls-Pascual, E.Mourino, C.Vazquez Rodriguez, T. R.Pego-Reigosaon, J. M.RELESSER EASSER2025-01-072025-01-072021-06-010003-4967https://hdl.handle.net/10668/25104enARE ANTIMALARIALS SAFE FOR THE HEART OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS? ANALYSIS OF FACTORS ASSOCIATED WITH THE DEVELOPMENT OF HEART FAILURE IN PATIENTS IN THE SPANISH SOCIETY OF RHEUMATOLOGY LUPUS REGISTRY (RELESSER)conference outputopen access10.1136/annrheumdis-2021-eular.12081468-2060https://ard.bmj.com/content/annrheumdis/80/Suppl_1/610.full.pdf692649600387